Hormonal changes during the first year of oestrogen treatment in constitutionally tall girls
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Oestrogens are used to inhibit growth in girls with constitutionally tall stature. We studied the changes in different hormones that accompany such therapy. SUBJECTS AND METHODS: In this longitudinal study we examined the levels of total insulin-like growth factor-I (IGF-I), free thyroxine (FT(4)), thyrotrophin (TSH), testosterone, dehydroepiandrosterone sulphate (DHEA-S), cortisol and prolactin in two groups of girls receiving ethinyloestradiol at a dose of either 0.1mg daily (group A, n=22) or 0.2mg daily (group B, n=36). Hormonal measurements were performed at start of therapy and after 3, 6 and 12 months. RESULTS: In both groups the levels of IGF-I, testosterone and DHEA-S were reduced while the concentrations of cortisol and prolactin were increased. The pituitary-thyroid axis was not significantly affected by this therapy. The girls receiving 0.2mg ethinyloestradiol daily had lower IGF-I levels after 12 months of therapy and had higher serum prolactin concentrations than the girls treated with 0.1mg daily. The reduction in predicted height and the advancement in bone age were similar in both groups. CONCLUSIONS: Therapy with pharmacological doses of ethinyloestradiol changes the levels of several hormones including IGF-I, testosterone, DHEA-S, prolactin and cortisol but the role of the respective changes in the inhibition of growth is not clear. The suppression of DHEA-S levels by 40% suggests that the ovaries contribute significantly to the production of this hormone in pubertal girls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
BOURGUIGNON, J.-P. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-4-467 · Cited by 158
Wiegratz, I., Jung-Hoffmann, C., & Kuhl, H. (1995) · Contraception · doi:10.1016/0010-7824(95)00098-u · Cited by 115 · cited 2×
“Accordingly, ethinyloestradiol in contraceptive doses also reduced DHEA-S levels by 20‐40% ( 27 , 28).”
Background
Cited by
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615
Pubertal neuromaturation, stress sensitivity, and psychopathology
WALKER, E. F., SABUWALLA, Z., & HUOT, R. (2004) · Development and Psychopathology · doi:10.1017/s0954579404040027 · Cited by 144
Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.
Walker, E. F., Brennan, P. A., Esterberg, M., Brasfield, J., Pearce, B., & Compton, M. T. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0018399 · Cited by 127
Walder, D. J., Trotman, H. D., Cubells, J. F., Brasfield, J., Tang, Y.-L., & Walker, E. F. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a1ff3 · Cited by 34
“, 2002) and longitudinal (Wajs-Kuto et al., 1999; Walker et al., 2001; Walker, 2002) studies, and has been implicated in the escalating risk of mental disorders during this period.”
BackgroundCoulon, N., Brailly-Tabard, S., Walter, M., & Tordjman, S. (2016) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2017.05.002 · Cited by 28
Metadata
- Authors
- Wajs-Kuto, E., De Beeck, L., Rooman, R., & Caju, M.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12-01
- Volume
- 141
- Issue
- 6
- Pages
- 579-584
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2122329454
- Cited by
- 13
- References
- 3
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.